Last update 21 Nov 2024

HRS-8179

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
SUR1
Mechanism
SUR1 inhibitors(Sulfonylurea receptor 1 inhibitors)
Therapeutic Areas
Nervous System DiseasesCardiovascular Diseases
Active Indication
Brain EdemaBrain InfarctionIschemic stroke
Inactive Indication-
Originator Organization
Beijing Suncadia Pharmaceuticals Co., Ltd
Active Organization
Beijing Suncadia Pharmaceuticals Co., Ltd
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with HRS-8179
CTR20223435 / Active, not recruitingPhase 2
注射用HRS8179治疗大面积缺血性脑卒中后严重脑水肿的有效性及安全性研究—多中心、随机、双盲、安慰剂对照、Ⅱ期临床试验
[Translation] Efficacy and safety of HRS8179 for injection in the treatment of severe cerebral edema after massive ischemic stroke: a multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial
NCT05690711 / Active, not recruitingPhase 2
Efficacy and Safety of Intravenous HRS8179 on Brain Swelling After Large Hemispheric Infarction: a Randomised, Double-blind, Placebo-controlled Phase II Trial
CTR20220165 / CompletedPhase 1
单中心、随机、双盲、安慰剂对照、剂量递增的I 期临床研究评估注射用HRS8179在中国健康受试者中单次给药的安全性、耐受性和药代动力学特征
[Translation] A single-center, randomized, double-blind, placebo-controlled, dose-escalating Phase I clinical study to evaluate the safety, tolerability and pharmacokinetic characteristics of HRS8179 for injection after a single dose in healthy Chinese subjects
100 Clinical Results associated with HRS-8179
Login to view more data
100 Translational Medicine associated with HRS-8179
Login to view more data
100 Patents (Medical) associated with HRS-8179
Login to view more data
100 Deals associated with HRS-8179
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Brain EdemaPhase 2
CN
Beijing Suncadia Pharmaceuticals Co., Ltd
07 Apr 2023
Brain InfarctionPhase 2
CN
Beijing Suncadia Pharmaceuticals Co., Ltd
07 Apr 2023
Ischemic strokePhase 2
CN
Beijing Suncadia Pharmaceuticals Co., Ltd
07 Apr 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free